참고문헌
- Guyatt GH, Feeny DH, Patrick DL. Measuring healthrelated quality of life. Ann Intern Med 1993;118:622-9. https://doi.org/10.7326/0003-4819-118-8-199304150-00009
- Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997;156(4 Pt 1):1032-9. https://doi.org/10.1164/ajrccm.156.4.97-02011
- Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155:1283-9. https://doi.org/10.1164/ajrccm.155.4.9105068
- Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85 Suppl B:25-31. https://doi.org/10.1016/S0954-6111(06)80166-6
- Kim YS, Byun MK, Jung WY, Jeong JH, Choi SB, Kang SM, et al. Validation of the Korean version of the St. George's respiratory questionnaire for patients with chronic respiratory disease. Tuberc Respir Dis 2006;61: 121-8. https://doi.org/10.4046/trd.2006.61.2.121
- Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer G, et al. Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest 2007;132: 1591-8. https://doi.org/10.1378/chest.07-0755
- Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997;156(2 Pt 1):536-41. https://doi.org/10.1164/ajrccm.156.2.9607083
- Lee BH, Kim YS, Lee KD, Lee JH, Kim SH. Health-related quality of life measurement with St. George's respiratory questionnaire in post-tuberculous destroyed lung. Tuberc Respir Dis 2008;65:183-90. https://doi.org/10.4046/trd.2008.65.3.183
- Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54. https://doi.org/10.1183/09031936.00102509
- Lee S, Lee JS, Song JW, Choi CM, Shim TS, Kim TB, et al. Validation of the Korean version of chronic obstructive pulmonary disease assessment test (CAT) and Dyspnea-12 questionnaire. Tuberc Respir Dis 2010;69: 171-6. https://doi.org/10.4046/trd.2010.69.3.171
- Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis 1986;134:1129-34.
- Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65:21-6. https://doi.org/10.1136/thx.2009.118521
- Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med 2003;97:1237-42. https://doi.org/10.1016/S0954-6111(03)00255-5
- Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in korean population. Tuberc Respir Dis 2005;58:230-42. https://doi.org/10.4046/trd.2005.58.3.230
- World Health Organization. Global tuberculosis control: WHO report 2011. Geneva: World Health Organization; 2011.
- Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest 2007;131:1817-24. https://doi.org/10.1378/chest.06-2949
- Barker AF. Bronchiectasis. N Engl J Med 2002;346:1383-93. https://doi.org/10.1056/NEJMra012519
피인용 문헌
- Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis vol.13, pp.None, 2012, https://doi.org/10.1186/1471-2466-13-21
- Perceived breathlessness and psychological distress among patients with chronic obstructive pulmonary disease and their spouses vol.16, pp.1, 2012, https://doi.org/10.1111/nhs.12073
- Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study vol.16, pp.None, 2015, https://doi.org/10.1186/s12931-015-0167-9
- Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation vol.17, pp.None, 2012, https://doi.org/10.1186/s12931-016-0380-1
- The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis vol.71, pp.8, 2012, https://doi.org/10.1136/thoraxjnl-2015-207315
- Dyspnoea-12: a translation and linguistic validation study in a Swedish setting vol.7, pp.5, 2012, https://doi.org/10.1136/bmjopen-2016-014490
- Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding vol.49, pp.3, 2012, https://doi.org/10.1183/13993003.02473-2016
- Investigation into the Individualized Treatment of Traditional Chinese Medicine through a Series of N-of-1 Trials vol.2018, pp.None, 2012, https://doi.org/10.1155/2018/5813767
- COPD Assessment Test (CAT) is a Valid and Simple Tool to Measure the Impact of Bronchiectasis on Affected Patients vol.15, pp.5, 2012, https://doi.org/10.1080/15412555.2018.1540034
- Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease vol.6, pp.1, 2012, https://doi.org/10.1136/bmjresp-2019-000418
- Effectiveness of non-pharmacological COPD management on health-related quality of life - a systematic review vol.20, pp.1, 2012, https://doi.org/10.1080/14737167.2020.1734455
- COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation vol.157, pp.4, 2012, https://doi.org/10.1016/j.chest.2019.08.1916
- A Series of N-of-1 Trials for Traditional Chinese Medicine Using a Bayesian Method: Study Rationale and Protocol vol.2021, pp.None, 2012, https://doi.org/10.1155/2021/9976770
- Adaptation and validation of the Chinese version of Dyspnoea‐12 scale in individuals with chronic obstructive pulmonary disease vol.15, pp.10, 2021, https://doi.org/10.1111/crj.13411
- Adaptation and validation of the Chinese version of Dyspnoea‐12 scale in individuals with chronic obstructive pulmonary disease vol.15, pp.10, 2021, https://doi.org/10.1111/crj.13411